Funding Pressures Impact Non-Originator Drugs In Germany, France and Italy
November 1, 2017
Pressure on public finances has led national governments across Europe to seek better control over healthcare expenditure. Healthcare funding pressure varies from country to country. However, pharmaceutical products are generally seen as a prime area where savings can be achieved. One way governments are looking to contain this area of expenditure is through shifting pharmaceutical consumption away from expensive branded products towards cheaper non-originator drugs (i.e. generics and biosimilars).
Competition and Markets Authority’s Care Homes Market Study
August 1, 2017
In December 2016, the Competition and Markets Authority (CMA) began a market study into care homes. The purpose was to explore how well the care home market works for residents and their families, and to review providers’ compliance with consumer protection law. They recently published their interim findings and where they intend to focus their investigation ahead of the final report publication by December 2017.
England’s Changing Primary Care Landscape
July 1, 2017
Primary care in England is changing. This is the result of a combination of national policy drivers, regulatory and contracting enablers, and service redesign.
Conservative Manifesto: A Reduced Role for Private Payers in Social Care
May 1, 2017
The publication of the Conservative manifesto last week highlighted a trend that followers of health and care policy making have seen for the last 6 months – the rise of adult social care on the political agenda